MedTrace Logo

Diagnostic Accuracy of On-line Quantitative Flow Ratio (QFR). FAVOR II Europe-Japan

NCT02959814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 329

Last updated 2020-01-13

Study results available
· View outcomes & findings →

Summary

Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. QFR is assessed by calculation of the pressure in the vessel based on two angiographic projections. The purpose of the FAVOR II study is to evaluate the diagnostic accuracy of on-line QFR compared to 2D Quantitative Coronary Angiography (QCA) with FFR as gold standard.

Conditions

Interventions

OTHER

QFR (observational)

QFR assessment by Medis Suite, Medis medical imaging B.V., The Netherlands

Sponsors & Collaborators

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Niels R. Holm, M.D. · Aarhus University Hospital, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-22
Primary Completion
2017-10-17
Completion
2018-06-01

Countries

  • Denmark
  • France
  • Germany
  • Italy
  • Japan
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02959814 on ClinicalTrials.gov